Kevin J. Anstrom

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

82h-index30.9kcitations496works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Heart Failure Treatment and Management(141), Cardiovascular Function and Risk Factors(81), Health Systems, Economic Evaluations, Quality of Life(54), Acute Myocardial Infarction Research(53), Cardiac pacing and defibrillation studies(51)

Publications482 total

Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trialau
UNC Libraries·2026Open Access
Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trial – CORRIGENDUM
Journal of Clinical and Translational Science·2026Open Access
Baseline characteristics of participants in the Biomarkers for Evaluating Spine Treatments clinical trial: a sequential multiple assignment randomized trial for chronic low back pain†
UNC Libraries·2025Open Access
Design characteristics of sequential multiple assignment randomised trials (SMARTs) for human health: a scoping review of studies between 2009 and 2024
BMJ Open·2025Open Access
The Journey to AI-Driven Autonomous Control
SPE Eastern Regional Meeting·2025
Blood Pressure, Safety and Clinical Efficacy of Vericiguat in Chronic Heart Failure with Reduced Ejection Fraction: Insights from the VICTOR Trial
European Journal of Heart Failure·2025· 4 cited
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
The Lancet·2025· 31 citedOpen Access
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
The Lancet·2025· 16 citedOpen Access
Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF
Journal of the American College of Cardiology·2025· 9 citedOpen Access
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial
European Heart Journal·2025· 11 citedOpen Access
Baseline characteristics of participants in the Biomarkers for Evaluating Spine Treatments clinical trial: a sequential multiple assignment randomized trial for chronic low back pain
Pain Medicine·2025Open Access
Assessing Benefit in Patients With Heart Failure and Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification
Journal of Cardiac Failure·2025· 1 cited
Mosaic loss of chromosome Y in blood is associated with male susceptibility for idiopathic pulmonary fibrosis
UNC Libraries·2025Open Access
Clinical endpoints in pragmatic heart failure trials: From data collection to clinical endpoint classification
UNC Libraries·2025Open Access
Clinical Endpoints in Pragmatic Heart Failure Trials: From Data Collection to Clinical Endpoint Classification
ESC Heart Failure·2025Open Access
Mosaic loss of chromosome Y in blood is associated with male susceptibility for idiopathic pulmonary fibrosis
Communications Medicine·2025· 4 citedOpen Access
Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge is Not Associated with Improvement in Quality of Life
The American Journal of Medicine·2025
Design characteristics of Sequential Multiple Assignment Randomized Trials (SMARTs) for human health: a scoping review of studies between 2009-2024
2025· 3 citedOpen Access
The Distribution of Coronary Plaque Volumes across CAD-RADS Categories: A PRECISE Substudy
Radiology Cardiothoracic Imaging·2025
SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality—a secondary analysis of the ACTIV-1 trial
UNC Libraries·2025Open Access
page 1 of 25Next →

Frequent Co-authors

Adrian F. Hernandez(15), G. Michael Felker(14), Steven E. McNulty(14), Margaret M. Redfield(13), Christopher M. O’Connor(10), Marc J. Semigran(8), W.H. Wilson Tang(8), Martin M. LeWinter(7), Eric J. Velazquez(7), Douglas L. Mann(7), David J. Whellan(7), Steven R. Goldsmith(6), Horng H. Chen(6), Michael M. Givertz(6), Javed Butler(6), Kerry L. Lee(6), Daniel B. Mark(6), Kenneth B. Margulies(6), Patrice Desvigne‐Nickens(6), Lynne W. Stevenson(5)